Lilit Karapetyan, MD

Articles by Lilit Karapetyan, MD

Expanding Access to TIL Therapy via Reduced-Intensity Conditioning

ByLilit Karapetyan, MD

April 8th 2026

Lilit Karapetyan, MD, MS, discusses a single-center trial of reduced-intensity conditioning before tumor-infiltrating lymphocyte therapy in melanoma.

Reduced Lymphodepletion With TILs Shows Promise in High-Risk Melanoma

ByJonah Feldman,Lilit Karapetyan, MD

April 7th 2026

A single-center study showed positive outcomes of reduced-intensity conditioning for tumor-infiltrating lymphocytes in melanoma.

Latest Updated Articles